Red Sun Expects Net Profits of RMB 95-105 Million in H1 2026

Hebang Biotechnology Expects a YoY Surge of 614.68%-730.57% in H1 2026 Net Profits

Haisco Pharmaceutical Projects a Surge of 513.25%-575.35% YoY in H1 2026 Net Profits

COFCO Biotechnology Expects a Net Loss of RMB 150-190 Million in H1 2026

Zhengbang Technology Reports a Net Loss of RMB 700-800 Million in H1 2026

Xiwang Foodstuffs Projects Net Profits of RMB 200-250 Million in H1 2026

Meihua Holdings: H1 2026 Net Profits are Estimated to Fall 55%-66% YOY

China’s Amino Acid Market: Methionine and Threonine Prices Edge Down, and Other Products Remain Weakly Stable; End Users Buy as Needed at Negotiated Prices

China’s Vitamin Market: Weak Consolidation Persists as Tepid Demand Drives Hand-to-Mouth Buying

China’s Vitamin Market Consolidates Weakly as Select Producers Schedule Maintenance; European Market Softens Broadly